Free Trial
LON:IQAI

IQ-AI 4/25/2025 Earnings Report

IQ-AI logo
GBX 0.81 -0.09 (-9.89%)
As of 05/2/2025 11:39 AM Eastern

IQ-AI EPS Results

Actual EPS
-GBX 0.15
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

IQ-AI Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

IQ-AI Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

IQ-AI Earnings Headlines

IQ-AI (LON:IQAI) Trading Down 1.7% - Time to Sell?
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
IQ-AI reports early success in glioblastoma study
See More IQ-AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IQ-AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IQ-AI and other key companies, straight to your email.

About IQ-AI

IQ-AI (LON:IQAI), through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company was incorporated in 1965 and is based in Saint Helier, Jersey.

View IQ-AI Profile

More Earnings Resources from MarketBeat